학술논문
Immunogenicity of Cemiplimab: Low Incidence of Antidrug Antibodies and Cut-Point Suitability Across Tumor Types
Document Type
Article
Author
Source
In: Journal of Clinical Pharmacology . (Journal of Clinical Pharmacology, January 2024, 64(1):125-136)
Subject
Language
English
ISSN
15524604
00912700
00912700